Pharmerica (PMC) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/9/2026
- Wall St futures inch higher as chips extend gains
- Oil falls as investors await clarity after Iran-Israel halt attacks
- Tech stocks gain as Trump mulls government stake in AI companies
- Morgan Stanley’s Wilson calls Friday U.S. selloff a "healthy reset"
- Hedge funds loaded up on equities ahead of sharp Friday drop
- Hut 8 Mining Corp. (HUT) PT Raised to $55 at KBW As Management Delivers
- Exclusive-SpaceX plans to set IPO price at $135 per share, targeting record $75 billion raise, source says
- Salesforce to acquire metering platform M3TER for consumption billing
- Quantum Space to go public via $1.2B SPAC merger
- SpaceX sets $135 price for blockbuster IPO, upending Wall Street convention
PharMerica Reports Second Quarter 2015 Results
August 7, 2015 8:00 AM EDTSolid Year Over Year Improvement in Revenue and Adjusted EBITDA
Industry Leading Generic Dispensing Rate Increases To Record 86%
Reaffirms Annual 2015 Guidance
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the second quarter ended June 30, 2015.
      2Q15 Results    ÂComparison to
2Q14
    Comparison to1Q15
Revenue     $497.5 million     Increase of 10.9%     Decrease of 2.8% Adjusted EBITDA     $33.2 million     ... More